Growth Hormone Secretion Following the Anaerobic Exercise
NCT01934270 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2019-10-15
Summary
Proper growth in children is a complex process regulated by a combination of genetic, nutritional, environmental, hormonal, and others. Growth hormone (GH) is the main hormone regulating the growth from childhood to adulthood. Despite great progress in the field, with the development of recombinant GH for the treatment of growth hormone deficiency (GHD), there is still no reliable method for testing GHD. Physical exertion is one of the significant physiologic stimuli for GH secretion, and it is reliable test for identification of GHD. It is not in use in the clinics because of its complexity. Recently GH secretion following short anaerobic exercise in young adults was tested and also demonstrated significant growth hormone secretion
In contrast to adult children's exercise is characterized by an anaerobic nature. There is no data about secretion of growth hormone in response to anaerobic exercise in children.
Purpose of the experiment:
The purpose of this study is to evaluate the secretion of growth hormone in response to anaerobic exercise in children.
Conditions
- Short Stature
- Obesity, Childhood
Interventions
- OTHER
-
Anaerobic Test
To evaluate the secretion of growth hormone in response to anaerobic exercise in children.
Sponsors & Collaborators
-
Meir Medical Center
lead OTHER
Principal Investigators
-
Dan Nemet, MD · Meir Medical Center , Tel Aviv University
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2019-12-30
- Completion
- 2020-03-01
Countries
- Israel
Study Locations
More Related Trials
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency
NCT00572156 ·Status: TERMINATED ·Phase: PHASE2
-
Growth Hormone Treatment on Phosphocreatine Recovery in Obesity
NCT01421589 ·Status: COMPLETED ·Phase: NA
-
Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment
NCT03005561 ·Status: UNKNOWN ·Phase: NA
-
Exploring Interactions Between Growth Hormone and the Microbiome
NCT03327207 ·Status: UNKNOWN
-
Effect of Nutritional Formula Supplementation on Growth Rate of Growth Hormone (GH) Treated Children With Growth Hormone Deficiency (GHD) After the Second Year of Therapy
NCT03053687 ·Status: RECRUITING ·Phase: NA
-
Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT00458263 ·Status: COMPLETED ·Phase: PHASE4
-
A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height
NCT00840944 ·Status: UNKNOWN ·Phase: PHASE4
-
Skeletal Muscle Effects of GH in Boys
NCT04020913 ·Status: COMPLETED
-
Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
NCT00174187 ·Status: TERMINATED ·Phase: PHASE3
-
Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
NCT00187993 ·Status: UNKNOWN
-
GH and Cardiovascular Risk Factors
NCT01877512 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle
NCT03878992 ·Status: UNKNOWN ·Phase: NA
-
Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)
NCT02507245 ·Status: COMPLETED
-
Study of the Molecular Basis in the Pathophysiology of Food Intake and Growth in Children
NCT00830141 ·Status: COMPLETED
-
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
NCT00182091 ·Status: COMPLETED ·Phase: NA
-
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
NCT02616562 ·Status: COMPLETED ·Phase: PHASE2
-
Growth Hormone and Endothelial Function in Children
NCT00373386 ·Status: COMPLETED ·Phase: PHASE4
-
Growth Hormone and Chromosome 18q- and Abnormal Growth
NCT00134420 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature
NCT01970800 ·Status: WITHDRAWN ·Phase: NA
-
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
NCT00324064 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
NCT02968004 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Nutritional Formula Supplementation on Linear Growth of Growth Hormone (GH) Treated Prepubertal Children With Idiopathic Short Stature (ISS) After 2 Years From the Beginning of GH-therapy
NCT04962360 ·Status: RECRUITING ·Phase: NA
-
Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy
NCT03672617 ·Status: COMPLETED
-
Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone
NCT01626833 ·Status: COMPLETED ·Phase: PHASE2/PHASE3